These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18162338)

  • 1. Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy.
    Cohen I
    Maturitas; 2008 Jan; 59(1):99-100. PubMed ID: 18162338
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormones and cancer.
    Shang Y
    Cell Res; 2007 Apr; 17(4):277-9. PubMed ID: 17426695
    [No Abstract]   [Full Text] [Related]  

  • 3. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
    McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
    Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy.
    Corley D; Rowe J; Curtis MT; Hogan WM; Noumoff JS; Livolsi VA
    Obstet Gynecol; 1992 Jan; 79(1):111-6. PubMed ID: 1727568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy.
    Antunes A; Costa-Paiva L; Arthuso M; Costa JV; Pinto-Neto AM
    Maturitas; 2007 Aug; 57(4):415-21. PubMed ID: 17587515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endometrial cancers arising in polyps associated with tamoxifen use].
    Mbatsogo BA; Le Bouëdec G; Michy T; Bourdel N; Fouilloux G; Dauplat J
    Gynecol Obstet Fertil; 2005 Dec; 33(12):975-9. PubMed ID: 16321556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tamoxifen and giant endometrial polyps].
    Caschetto S; Cassaro N; Consalvo P; Caragliano L
    Minerva Ginecol; 2000 Nov; 52(11):459-63. PubMed ID: 11256174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
    Schmidt D; Horn LC
    Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
    Cohen I
    Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
    Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent endometrial polyps in postmenopausal breast cancer patients on tamoxifen.
    Biron-Shental T; Tepper R; Fishman A; Shapira J; Cohen I
    Gynecol Oncol; 2003 Aug; 90(2):382-6. PubMed ID: 12893204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen use as a malignancy risk factor in postmenopausal women with endometrial polyps.
    Yela DA; Ikejiri TA; Machado CR; Mutta D; Benetti-Pinto CL
    Menopause; 2019 Aug; 26(8):863-866. PubMed ID: 30969185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign and malignant diseases of the endometrium.
    Chaudhry S; Reinhold C; Guermazi A; Khalili I; Maheshwari S
    Top Magn Reson Imaging; 2003 Aug; 14(4):339-57. PubMed ID: 14578778
    [No Abstract]   [Full Text] [Related]  

  • 15. Massive endometrial polyp after tamoxifen therapy.
    Divers MJ
    Br J Clin Pract; 1995; 49(5):275-6. PubMed ID: 7492471
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen-induced endometrial polyp.
    Neven P; De Muylder X; Van Belle Y
    N Engl J Med; 1997 May; 336(19):1389; author reply 1389-90. PubMed ID: 9139225
    [No Abstract]   [Full Text] [Related]  

  • 17. Endometrial decidual changes in a postmenopausal woman treated with tamoxifen and megestrol acetate.
    Cohen I; Shapira J; Altaras M; Cordoba M; Rosen D; Beyth Y
    Br J Obstet Gynaecol; 1992 Sep; 99(9):773-4. PubMed ID: 1420020
    [No Abstract]   [Full Text] [Related]  

  • 18. Endometrial cancer in polyps associated with tamoxifen use.
    Ramondetta LM; Sherwood JB; Dunton CJ; Palazzo JP
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):340-1. PubMed ID: 9988797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis.
    Wu H; Chen Y; Liang J; Shi B; Wu G; Zhang Y; Wang D; Li R; Yi X; Zhang H; Sun L; Shang Y
    Nature; 2005 Dec; 438(7070):981-7. PubMed ID: 16355216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Images in clinical medicine. Tamoxifen-induced endometrial polyp.
    Timmerman D; Vergote I
    N Engl J Med; 1996 Nov; 335(22):1650. PubMed ID: 8929362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.